Ugar Sugar Works jumps 11.1% after CareEdge upgrades rating on sharp profit turnaround

Ugar Sugar Works Ltd’s stock surged 11.1% in the latest session after the company disclosed a fresh credit opinion from CareEdge Ratings. The note did more than just tweak a rating — it laid out a clear improvement in the company’s earnings profile, liquidity and risk perception, which appears to have driven the market reaction.

What CareEdge changed — and why it matters

According to the CareEdge press release dated August 13, 2026 (attached to the company’s filing), the rating agency:

• Upgraded Ugar Sugar Works’ long-term bank facilities of ₹700.00 crore to CARE BBB-; Stable, from CARE BB+; Negative.
• Withdrew the rating on the company’s fixed deposit programme, which is now shown at ₹0.00 crore.

The key here is not just the move from CARE BB+; Negative to CARE BBB-; Stable, but the shift in outlook from ‘Negative’ to ‘Stable’. On page 2, CareEdge states that the upgrade reflects “significant improvement in the company’s profitability” supported by:

• Growth in sales volume and sugar realisation.
• Better co-generation power segment performance in FY26 and Q1FY27.

The agency also notes that earlier concerns around sizeable debt repayments of ~₹50 crore p.a. each in FY26 and FY27 are now “substantially mitigated” by improved profitability, which it expects to continue in FY27.

For equity investors, a move into the BBB band with a stable outlook typically signals lower perceived credit risk and a reduced probability of financial stress, which can justify a re-rating in the stock.

Earnings have turned a corner

The rating action is grounded in a visible turnaround in the company’s standalone financials.

On page 3, CareEdge highlights that Ugar Sugar’s scale of operations grew by 11% year-over-year in FY26, with total operating income rising to ₹1,490.22 crore from ₹1,333.50 crore in FY25.

The profitability improvement is even more striking:

• PBILDT (profit before interest, lease rentals, depreciation and tax) increased to ₹106.44 crore in FY26 from ₹44.69 crore in FY25 (page 5).
• The press release notes that PBILDT margin expanded by ~370 bps year-over-year in FY26 (page 2).
• Profit after tax (PAT) swung from a loss of ₹16.25 crore in FY25 to a profit of ₹13.61 crore in FY26 (page 5).

CareEdge explicitly links this to:

• Better sugar recovery and growth in sugar realisations.
• A higher revenue share from the industrial alcohol segment.

Crucially, this turnaround came despite cost pressures. The agency points out that manufacturing expenses rose by ~₹50 crore in FY26 due to a Government of Karnataka directive requiring mills to pay additional charges over and above the fair and remunerative price (FRP) to farmers (page 3). Even with this higher cane cost, Ugar Sugar generated significantly higher PBILDT, which strengthens the quality of the improvement.

Q1FY27 performance supports the upgrade

The latest quarter’s numbers, though unaudited, show the trend continuing (page 5):

• Total operating income for the quarter ended June 30, 2026 stood at ₹480.93 crore.
• PBILDT for the same period was ₹26.73 crore.
• PAT came in at ₹1.49 crore.

CareEdge cites this Q1FY27 performance as part of the rationale for expecting profitability to remain healthy in FY27, supported by higher sugar prices and the expectation of maintaining sugarcane crushing levels comparable to the previous season (page 3).

Liquidity and leverage: still a risk, but improving

The rating report acknowledges that Ugar Sugar’s balance sheet remains stretched, but with signs of improvement:

• Overall gearing stood at 3.13x as on March 31, 2026, unchanged from 3.13x a year earlier (page 3 and page 5).
• Total outside liabilities to total net worth was 4.98x as on March 31, 2026, versus 4.6x as on March 31, 2025 (page 3).
• PBILDT interest coverage improved to 1.74x as on March 31, 2026, from 0.92x in FY25 (page 4 and page 5).
• Total debt/PBILDT stood at 6.82x as on March 31, 2026 (page 4).

On liquidity (page 4):

• The company repaid term debt worth ₹13.5 crore in Q1FY27.
• Average monthly working capital utilisation was high at 94% for the 12 months ending March 2026, but had reduced to 85% as of June 2026.
• Ugar Sugar had cash and bank balance of ₹3.33 crore as on March 31, 2026.

CareEdge describes liquidity as “Adequate” and expects it to improve, assuming the company delivers the envisaged profitability in FY27.

The Stable outlook is explicitly tied to expectations that Ugar Sugar will generate adequate cash accruals, maintain adequate debt coverage metrics, and that there are no major debt-funded capex plans in the medium term (page 3).

Integrated model and ethanol pivot underpin the story

Beyond the numbers, the agency emphasises structural strengths that help explain why the market may have welcomed the rating action:

• Ugar Sugar operates with a total installed capacity of 24,200 TCD of sugarcane crushing, a 59.50 MW co-generation unit and an 845-KLPD multi-feed distillery (page 4).
• The company commissioned an 800 KLPD direct route-based ethanol plant in FY23, which can be converted to a 400-KLPD grain-based ethanol plant in the offseason (page 4).
• CareEdge notes that the company plans to operate the distillery on maize/FCI rice in the first half of the current fiscal year to “ensure better margins” (page 3).

The report also highlights diversified revenue streams from sugar, ethanol and co-generation, which mitigate some of the cyclicality and seasonality of the sugar business (page 2).

Why the stock likely reacted the way it did

Putting it together, the 11.1% move in Ugar Sugar Works’ stock after the filing appears to be driven mainly by:

1. A clear shift in credit risk perception: Moving from CARE BB+; Negative to CARE BBB-; Stable on ₹700.00 crore of long-term bank facilities is a meaningful upgrade that can lower borrowing costs over time and reduce default risk perceptions.
2. A demonstrated earnings turnaround: FY26 saw an 11% rise in total operating income to ₹1,490.22 crore, a jump in PBILDT to ₹106.44 crore, and a swing from a ₹16.25 crore loss to ₹13.61 crore profit, despite higher cane costs.
3. Evidence that the trend is continuing: Q1FY27 numbers (₹480.93 crore in total operating income and ₹26.73 crore PBILDT) and term-debt repayment of ₹13.5 crore support CareEdge’s expectation of sustained performance.
4. Improving liquidity and working capital metrics: Lower working capital utilisation (from 94% to 85%) and an “Adequate” liquidity assessment reduce near-term stress concerns.

The filing does not provide any information on market valuations, investor positioning or broader sector flows, so those factors cannot be assessed from the document. But based solely on the disclosed data, the combination of a rating upgrade, a stronger profit profile and a more comfortable liquidity outlook provides a reasonable explanation for the stock’s strong 11.1% session.